PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
AssigneeSanofi-Aventis Deutschland GmbH
InventorsMarc NAZARE, Volkmar WEHNER, David W. WILL, Hans MATTER
Life of this patent
Estimating the term…
Loading patent…
AssigneeSanofi-Aventis Deutschland GmbH
InventorsMarc NAZARE, Volkmar WEHNER, David W. WILL, Hans MATTER
Estimating the term…
The present invention is directed to a compound of formula I, in which R0; R1; R2; R3; R4; Q; V, G and M have the meanings indicated in the claims. the compound of formula I is valuable pharmacologically active compounds. They exhibit a strong antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses. They are reversible inhibitors of the blood clotting enzymes factor Xa (FXa) and/or factor VIIa (FVIIa), and can in general be applied in conditions in which an undesired activity of factor Xa and/or factor VIIa is present or for the cure or prevention of which an inhibition of factor Xa and/or factor VIIa is intended. The invention furthermore is directed to processes for the preparation of a compound of formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.
A compound of formula I,
Dependencies are inferred from the claim text.